Unknown

Dataset Information

0

Replication competent molecular clones of HIV-1 expressing Renilla luciferase facilitate the analysis of antibody inhibition in PBMC.


ABSTRACT: Effective vaccine development for human immunodeficiency virus type 1 (HIV-1) will require assays that ascertain the capacity of vaccine immunogens to elicit neutralizing antibodies (NAb) to diverse HIV-1 strains. To facilitate NAb assessment in peripheral blood mononuclear cell (PBMC)-based assays, we developed an assay-adaptable platform based on a Renilla luciferase (LucR) expressing HIV-1 proviral backbone. LucR was inserted into pNL4-3 DNA, preserving all viral open reading frames. The proviral genome was engineered to facilitate expression of diverse HIV-1 env sequences, allowing analysis in an isogenic background. The resulting Env-IMC-LucR viruses are infectious, and LucR is stably expressed over multiple replications in PBMC. HIV-1 neutralization, targeting TZM-bl cells, was highly correlative comparing virus (LucR) and cell (firefly luciferase) readouts. In PBMC, NAb activity can be analyzed either within a single or multiple cycles of replication. These results represent advancement toward a standardizable PBMC-based neutralization assay for assessing HIV-1 vaccine immunogen efficacy.

SUBMITTER: Edmonds TG 

PROVIDER: S-EPMC2993081 | biostudies-literature | 2010 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Replication competent molecular clones of HIV-1 expressing Renilla luciferase facilitate the analysis of antibody inhibition in PBMC.

Edmonds Tara G TG   Ding Haitao H   Yuan Xing X   Wei Qing Q   Smith Kendra S KS   Conway Joan A JA   Wieczorek Lindsay L   Brown Bruce B   Polonis Victoria V   West John T JT   Montefiori David C DC   Kappes John C JC   Ochsenbauer Christina C  

Virology 20100921 1


Effective vaccine development for human immunodeficiency virus type 1 (HIV-1) will require assays that ascertain the capacity of vaccine immunogens to elicit neutralizing antibodies (NAb) to diverse HIV-1 strains. To facilitate NAb assessment in peripheral blood mononuclear cell (PBMC)-based assays, we developed an assay-adaptable platform based on a Renilla luciferase (LucR) expressing HIV-1 proviral backbone. LucR was inserted into pNL4-3 DNA, preserving all viral open reading frames. The prov  ...[more]

Similar Datasets

| S-EPMC8268740 | biostudies-literature
| S-EPMC2565673 | biostudies-literature
| S-EPMC5856552 | biostudies-literature
| S-EPMC2922018 | biostudies-literature
| S-EPMC4431758 | biostudies-literature
| S-EPMC3419657 | biostudies-literature
| S-EPMC4021088 | biostudies-literature
| S-EPMC6165844 | biostudies-literature
| S-EPMC2700051 | biostudies-literature
| S-EPMC51675 | biostudies-other